πŸ‡ΊπŸ‡Έ FDA
Patent

US 10738004

Cyclic compound

granted A61KA61K31/235A61P

Quick answer

US patent 10738004 (Cyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/235, A61P, A61P1/16, A61P25/02